Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021. Pooja Nayak, Tamar Polonsky, Lu Tian, Philip Greenland, Shujun Xu, Dongxue Zhang, Lihui Zhao, Michael H Criqui, Melina R Kibbe, Barbara Gladders, Philip Goodney, Karen Ho, Jack M Guralnik, Mary M McDermott
No abstract text is available yet for this article.
Full text links Group 7 Search Heart failure treatment Papers Topics Collections Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents- sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducing September 1, 2017: JAMA Cardiology Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininine Jul, 2011: European Journal of Heart Failure Randomized Controlled Trial Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. Revie w Get seemless 1-tap access through your institution/university For the best experience, use the Read mobile app Get app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our